Solving the puzzle of spinal muscular atrophy: What are the missing pieces?
- 3 October 2013
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 161 (11) , 2836-2845
Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive, lower motor neuron disease. Clinical heterogeneity is pervasive: three infantile (type I–III) and one adult‐onset (type IV) forms are recognized. Type I SMA is the most common genetic cause of death in infancy and accounts for about 50% of all patients with SMA. Most forms of SMA are caused by mutations of the survival motor neuron (SMN1) gene. A second gene that is 99% identical to SMN1 (SMN2) is located in the same region. The only functionally relevant difference between the two genes identified to date is a C → T transition in exon 7 of SMN2, which determines an alternative spliced isoform that predominantly excludes exon 7. Thus, SMN2 genes do not produce sufficient full length SMN protein to prevent the onset of the disease. Since the identification of the causative mutation, biomedical research of SMA has progressed by leaps and bounds: from clues on the function of SMN protein, to the development of different models of the disease, to the identification of potential treatments, some of which are currently in human trials. The aim of this review is to elucidate the current state of knowledge, emphasizing how close we are to the solution of the puzzle that is SMA, and, more importantly, to highlight the missing pieces of this puzzle. Filling in these gaps in our knowledge will likely accelerate the development and delivery of efficient treatments for SMA patients and be a prerequisite towards achieving our final goal, the cure of SMA.Keywords
This publication has 134 references indexed in Scilit:
- Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophyBrain Research, 2012
- Spinal muscular atrophy: The role of SMN in axonal mRNA regulationBrain Research, 2012
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse modelNature, 2011
- RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMNNature Biotechnology, 2010
- Intron 7 conserved sequence elements regulate the splicing of the SMN genesHuman Genetics, 2009
- SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCREuropean Journal of Human Genetics, 2009
- Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?Nature Reviews Neuroscience, 2009
- Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibitionHuman Molecular Genetics, 2008
- SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in SplicingCell, 2008
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic MiceThe American Journal of Human Genetics, 2008